Harbour Antibodies

OverviewSuggest Edit

Harbour Antibodies BV was established in 2006 to use transgenic mouse technology developed in the laboratory of Professor Frank Grosveld at Erasmus MC (Rotterdam, the Netherlands) for engineering mice to produce high affinity human antibodies. The company has developed two types of human immunoglobulin gene transgenic mice: mice that generate “conventional” tetrameric antibodies comprising two heavy and two light immunoglobulin chains (H2L2); and alternatively, mice that generate heavy chain only antibodies comprising two immunoglobulin heavy chains with no light chains (HCAbs). Availability of HCAbs facilitates the generation of soluble human VH domains (human heavy chain variable region domains), the minimal immunoglobulin recognition unit, and thus the construction of novel multi-functional molecules comprising either two (or more) VH domains or one VH domain coupled to other molecules. Both Harbour transgenic mouse lines are now available to licensing partners.
TypePrivate
Founded2006
HQCambridge, US
Websiteharbourantibodies.com

Locations

Harbour Antibodies is headquartered in
Cambridge, United States

Location Map

Latest Updates

Employees (est.) (Sep 2019)3

Key People/Management at Harbour Antibodies

Robert Kamen

Robert Kamen

Director
Frank Grosveld

Frank Grosveld

CSO and Founder
Show more

Harbour Antibodies Office Locations

Harbour Antibodies has an office in Cambridge
Cambridge, US (HQ)
Cambridge, MA 02141, USA
Show all (1)

Harbour Antibodies Financials and Metrics

Summary Metrics

Founding Date

2006

Harbour Antibodies total Funding

$3.2 m

Harbour Antibodies latest funding size

$3.20 m

Time since last funding

6 years ago

Harbour Antibodies investors

Harbour Antibodies's latest funding round in July 2013 was reported to be $3.2 m. In total, Harbour Antibodies has raised $3.2 m
Show all financial metrics

Harbour Antibodies Online and Social Media Presence

Embed Graph

Harbour Antibodies Frequently Asked Questions

  • When was Harbour Antibodies founded?

    Harbour Antibodies was founded in 2006.

  • Who are Harbour Antibodies key executives?

    Harbour Antibodies's key executives are Robert Kamen and Frank Grosveld.

  • How many employees does Harbour Antibodies have?

    Harbour Antibodies has 3 employees.

  • Who are Harbour Antibodies competitors?

    Competitors of Harbour Antibodies include GrayBug, Rebiotix and PellePharm.

  • Where is Harbour Antibodies headquarters?

    Harbour Antibodies headquarters is located at Cambridge, MA 02141, USA, Cambridge.

  • Where are Harbour Antibodies offices?

    Harbour Antibodies has an office in Cambridge.

  • How many offices does Harbour Antibodies have?

    Harbour Antibodies has 1 office.